Fighting COVID-19 proved a boon to cancer research. Here’s how scientists are using the same mRNA technology to attack tumors.
Author: Karen Weintraub, USA TODAY
It’s been 40 years since the first reported cases of AIDS. While treatments have come a long way, a vaccine remains elusive.
The parallels between AIDS/HIV and COVID-19 and the virus that causes it are stark. But the differences are striking, too.
‘Life-altering:’ As millions cope with smell loss from COVID-19, researchers find new explanations and possible treatments
Smell loss afflicts the majority of those with COVID-19. A new understanding is emerging about what causes it, and eventually, how it might be treated.
CDC reports 13 additional cases of blood clots linked to J&J COVID-19 vaccine. All happened before 11-day pause in its use.
The newly revealed cases all occurred in people before the government’s 11-day pause in J&J’s single-dose vaccine last month.
Pfizer-BioNTech seeks full FDA approval for COVID-19 vaccine
Like other vaccines available in the U.S., Pfizer-BioNTech have been providing their vaccine under an emergency use authorization.
An experimental gene therapy was little Alissa’s only hope. Now, instead of certain death, she faces an uncertain future.
A scientific vision for decades, gene therapy is finally becoming more common in the U.S., fueling optimism for the treatment of rare diseases.
‘The benefits outweigh the risks’: It’s time to allow J&J’s COVID-19 vaccine again, public health experts say
A government advisory committee will meet Friday to determine whether to lift the hold on the single-dose vaccine hailed as a “game-changer.”
‘Like somebody gave me a happy pill:’ Monoclonal antibodies are helping the Americans most at risk for COVID-19
The therapy can be life-saving, especially in the early stages of an infection, and it’s becoming easier to access across the US.
Pfizer COVID-19 vaccine is 90% effective for at least 6 months and protects against South Africa variant, study shows
Volunteers receiving a second dose of the Pfizer-BioNTech vaccine remained more than 90% protected against symptomatic COVID-19.
‘We’re skating on a knife’s edge right now’: Scientists worry US could be headed for yet another COVID-19 surge
Scientists worry that rising COVID-19 case numbers might be the beginning of a fourth surge, though they don’t expect it to be as bad as others.